These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25316265)

  • 1. A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist's perspective.
    Tanriverdi O
    Med Oncol; 2014 Nov; 31(11):282. PubMed ID: 25316265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging systems of hepatocellular carcinoma: a review of literature.
    Maida M; Orlando E; Cammà C; Cabibbo G
    World J Gastroenterol; 2014 Apr; 20(15):4141-50. PubMed ID: 24764652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effusion cytology of hepatocellular carcinoma with in situ hybridisation for human albumin.
    Stephen MR; Oien K; Ferrier RK; Burnett RA
    J Clin Pathol; 1997 May; 50(5):442-4. PubMed ID: 9215133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.
    Attallah AM; Omran MM; Attallah AA; Abdelrazek MA; Farid K; El-Dosoky I
    Int J Clin Oncol; 2017 Apr; 22(2):332-339. PubMed ID: 27864623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
    Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
    Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors and Staging Systems in Hepatocellular Carcinoma.
    Selçuk H
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):45-49. PubMed ID: 28301998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification.
    Camaggi CM; Zavatto E; Gramantieri L; Camaggi V; Strocchi E; Righini R; Merina L; Chieco P; Bolondi L
    Clin Chem Lab Med; 2010 Sep; 48(9):1319-26. PubMed ID: 20509833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Role of Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Level in Early Stage Hepatocellular Carcinoma.
    Lin J; Ko CJ; Hung YJ; Lin PY; Lin KH; Hsieh CE; Chou CT; Chen YL
    Sci Rep; 2020 Mar; 10(1):5651. PubMed ID: 32221384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis and secretion of serum albumin in Morris hepatomas 5123tc and 9121.
    Schreiber G; Urban J; Dryburgh H; Bradley TR
    Adv Exp Med Biol; 1977 May 22-24; 92():565-82. PubMed ID: 205109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas.
    Yamakado K; Hirota S
    World J Gastroenterol; 2015 Oct; 21(37):10604-8. PubMed ID: 26457020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
    Piñero F; Dirchwolf M; Pessôa MG
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.
    Qiao CX; Zhai XF; Ling CQ; Lang QB; Dong HJ; Liu Q; Li MD
    World J Gastroenterol; 2012 Jun; 18(21):2689-94. PubMed ID: 22690079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of fibrolamellar hepatocellular carcinoma.
    Chaudhari VA; Khobragade K; Bhandare M; Shrikhande SV
    Chin Clin Oncol; 2018 Oct; 7(5):51. PubMed ID: 30395718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
    Chiou SH; Lee KT
    Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
    Saad ZM; Fouad Y; Ali LH; Hassanin TM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
    Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
    Carr BI; Guerra V
    Int J Biol Markers; 2017 Oct; 32(4):e391-e396. PubMed ID: 28862714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma.
    Bağırsakçı E; Şahin E; Atabey N; Erdal E; Guerra V; Carr BI
    Oncology; 2017; 93(2):136-142. PubMed ID: 28486226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.